Calendar Finch Therapeutics Group, Inc.

Equities

FNCH

US31773D2009

Market Closed - OTC Markets 01:11:09 29/06/2024 am IST 5-day change 1st Jan Change
1.37 USD +2.24% Intraday chart for Finch Therapeutics Group, Inc. +3.01% -62.05%

Chart calendar Finch Therapeutics Group, Inc.

1c1ef11c75584e082f6d.s-iCStrwYt_I05qWYyVtUYJ0kvLfpf34GDL2OMHw0DQ.wIHwKb2BErmRi-v0BhAmM_VF6paAx6m6aHCbeZiC4n3RndUekMUj7fmi8Q~9368858cff6cd74177a858576e5fa44a

Upcoming events on Finch Therapeutics Group, Inc.

No events available

Past events on Finch Therapeutics Group, Inc.

10/06/2023 08:00 pm Annual General Meeting
10/05/2023 04:30 pm Q1 2023 Earnings Release
24/03/2023 01:35 am Q4 2022 Earnings Release
01/12/2022 09:50 pm Evercore ISI HealthCONx Conference
16/11/2022 04:25 pm Jefferies London Healthcare Conference
10/11/2022 05:30 pm Q3 2022 Earnings Release
11/08/2022 04:30 pm Interim 2022 Earnings Release
15/06/2022 11:30 pm JMP Securities Life Sciences Conference
10/06/2022 08:00 pm Annual General Meeting
10/06/2022 05:30 pm Jefferies Healthcare Conference
24/05/2022 04:30 pm H.C. Wainwright Global Life Sciences Investment Conference
16/05/2022 05:30 pm Business Update Call
16/05/2022 04:30 pm Q1 2022 Earnings Release
01/04/2022 02:26 am FY 2021 Earnings Release
02/03/2022 01:45 am Chardan Metagenomics and Microbiome Medicines Summit - Panel
13/01/2022 08:15 pm JP Morgan Healthcare Conference
10/01/2022 05:30 pm H.C. Wainwright BioConnect Conference
02/12/2021 08:35 pm Evercore ISI HealthCONx Conference
18/11/2021 01:30 pm Jefferies London Healthcare Conference - Pre- Recorded
10/11/2021 05:35 pm Q3 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
7,72


18,5
20,2
-8.32%
0,86
1,30
-33.77%
EBITDA
Million USD
Released
Forecast
Spread
0,00


-57,7
-77,3
25.39%
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-60,0
-67,0
10.41%
-95,1
-103
7.65%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-115
-104
-10.34%
Net income
Million USD
Released
Forecast
Spread
0,00


-58,2
-67,0
13.14%
-115
-104
-10.34%
EPS
USD
Released
Forecast
Spread
-9,90


-44,4
-51,5
13.7%
-72,0
-66,9
-7.62%
Announcement Date26/02/2131/03/2223/03/23

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales
Million USD
Released
Forecast
Spread



0,36
1,30
-72.23%
0,14
1,50
-90.8%
0,01
0,40
-98%
0,11
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread



-20,4
-22,0
7.47%












EBIT
Million USD
Released
Forecast
Spread



-21,7
-19,9
-9.45%
-21,3
-18,9
-12.72%
-27,5
-15,2
-80.98%
-18,1
-4,10
-341.41%
-9,08
-7,30
-24.38%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-22,7
-17,7
-28.25%
-40,4
-19,8
-103.89%
-27,0
-16,3
-65.69%
-67,4
-4,10
-1543.9%
-6,95
-7,30
4.79%
Net income
Million USD
Released
Forecast
Spread
-24,6


-22,7
-19,9
-14.36%
-40,4
-18,9
-113.6%
-27,0
-16,3
-65.69%
-63,9
-4,10
-1459.49%
-6,95
-7,30
4.79%
EPS
USD
Released
Forecast
Spread
-15,6


-14,4
-12,5
-15.66%
-25,5
-12,0
-112.5%
-16,8
-10,2
-64.71%
-39,9
-2,70
-1377.78%
-4,33
-4,50
3.78%
Announcement Date16/05/2211/08/2210/11/2223/03/2310/05/2310/08/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. FNCH Stock
  4. Calendar Finch Therapeutics Group, Inc.